Literature DB >> 29460077

Orofacial antinociceptive effect of sulphated polysaccharide from the marine algae Hypnea pseudomusciformis in rodents.

Caio Átila Prata Bezerra Souza1, Breytiner Amaro de Oliveira1, Sacha Aubrey Alves Rodrigues Santos1, Francisco Lucas Alves Batista2, Francisco Regivânio Nascimento Andrade3, Eugênio Januário Ramos Neto3, José de Maria Albuquerque de Melo Júnior1, Francisco Rogenio da Silva Mendes1, Lana Karine Vasconcelos Barroso1, Kirley Marques Canuto4, Francisco Ernani Alves Magalhães1,2, Angelo Roncalli Alves E Silva1, Wladimir Ronald Lobo Farias3, Adriana Rolim Campos5.   

Abstract

This study aimed to evaluate the antinociceptive effect of sulphated polysaccharide from the marine algae Hypnea pseudomusciformis (PLS) using rodent models of orofacial pain. Acute pain was induced by formalin, capsaicin, cinnamaldehyde, acidified saline or glutamate (cutaneous modes) and hypertonic saline (corneal model). In one experiment, animals were pretreated with ruthenium red, glibenclamide, naloxone, L-NAME, methylene blue or ketamine to investigate the mechanism of antinociception. In another experiment, animals pretreated with PLS or saline were submitted to the temporomandibular joint formalin test. In yet another, animals were submitted to craniofacial pain induced by mustard oil. Motor activity was evaluated with the open-field test. Cytotoxicity and antioxidant activities were also assessed. Pre-treatment with PLS significantly reduced nociceptive behavior associated with acute pain. Antinociception was effectively reduced, but not inhibited, by ruthenium red and ketamine. L-NAME and glibenclamide enhanced the PLS effect. PLS antinociception was resistant to methylene blue, naloxone and heating. PLS presented no cytotoxicity or antioxidant properties. Our results confirm the potential pharmacological relevance of PLS as an inhibitor of orofacial nociception in acute pain probably mediated by glutamatergic, nitrergic, TRPs and K + ATP pathways.

Entities:  

Keywords:  Hypnea pseudomusciformis; Orofacial antinociception; Sulphated polysaccharide

Mesh:

Substances:

Year:  2018        PMID: 29460077     DOI: 10.1007/s10787-018-0454-4

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  1 in total

1.  Development of a Nanoformulation for Oral Protein Administration: Characterization and Preclinical Orofacial Antinociceptive Effect.

Authors:  Marina de Barros Mamede Vidal Damasceno; Sacha Aubrey Alves Rodrigues Santos; João Ronielly Campêlo Araújo; Lana Karine Vasconcelos Barroso; Samara Casemiro Benevides; Francisco Ernani Alves Magalhães; Kaio César Simiano Tavares; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira; Angelo Roncalli Alves E Silva; Adriana Rolim Campos
Journal:  AAPS PharmSciTech       Date:  2022-08-25       Impact factor: 4.026

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.